Perspective on the Therapeutics of Anti-Snake Venom [PDF]
Snakebite envenomation is a life-threatening disease that was recently re-included as a neglected tropical disease (NTD), affecting millions of people in tropical and subtropical areas of the world. Improvement in the therapeutic approaches to envenomation is required to palliate the morbidity and mortality effects of this NTD. The specific therapeutic
Andrea Salazar +2 more
exaly +6 more sources
Is anti‐snake venom required for all snakebites: A case report [PDF]
AbstractThe classification of snakebite is based on clinical examination and laboratory tests. In cases, of suspected hemotoxic snakebite, the anti‐snakebite venom (ASV) is administered based on 20‐minute whole blood clotting time. However, the use of ASV should be guided by the presence of bleeding diathesis along with raised clotting time.
Thinley Dorji
exaly +5 more sources
Delayed Neurological Manifestation in Krait Bites Despite Anti-snake Venom Therapy. [PDF]
A severe medical emergency that poses a life-threatening risk is envenomation from a snake bite. Among the several snake families, krait bites are known to result in neurological symptoms, including ptosis, headache, and sweating. A 12-year-old adolescent boy who had been bitten by a krait appeared in this instance.
Sawhney S +5 more
europepmc +3 more sources
Anti-snake Venom-Induced Kounis Syndrome: A Unique Case in the Emergency Department. [PDF]
Kounis syndrome is the concurrence of acute coronary syndromes associated with allergic or hypersensitivity and anaphylactic or anaphylactoid triggers. Although it is not a rare diagnosis, the different presentations and afflictions of all ages, sex, and racial groups make it a diagnostic challenge.
Verma A +4 more
europepmc +3 more sources
Knowledge assessment of anti-snake venom among healthcare practitioners in northern Nigeria. [PDF]
Introduction: Anti-snake venom (ASV) is the standard therapy for the management of snakebite envenoming (SBE). Therefore, the knowledge of ASV among healthcare practitioners (HCPs) is essential for achieving optimal clinical outcomes in snakebite management.
Bala AA +11 more
europepmc +6 more sources
Anti-snake venom therapy is the only treatment for snake bite but leads to acute and chronic conditions which may be severe. The medicinal plants have gained importance over years to find an effective alternative to anti-snake venom.
Shwetha Vasudev +3 more
doaj +3 more sources
Severe Pediatric Snakebite With Coagulopathy and Compartment Syndrome: Conservative Management With Plasma Exchange. [PDF]
Therapeutic plasma exchange was successfully used in a child with severe snakebite envenomation complicated by refractory venom‐induced consumptive coagulopathy and suspected compartment syndrome, leading to full recovery and avoidance of surgical intervention.
Al Muqbel ZM +8 more
europepmc +2 more sources
Characterization of Alpha-Bungarotoxin Antibodies Prepared by Different Strategies [PDF]
The preparation of an antibody to treat snake envenomation requires a large amount of snake venom. In China, only four types of anti-snake venom sera are clinically available, and the production and immunization strategies for clinically approved anti ...
Huijuan Lu +6 more
doaj +2 more sources
Comparison of Different Dosing Protocols of Anti-Snake Venom (ASV) in Snake Bite Cases. [PDF]
Considering the cost of Anti-Snake Venom (ASV) and irregularity in its supply, there is often a need to curtail doses of ASV, despite guidelines for management of snake bite. During June 2013 to September 2013, when ASV was in short supply, our institutional committee reviewed the overall hospital statistics of snake bite cases as well as scientific ...
Daswani BR +5 more
europepmc +4 more sources
From Snake Venom’s Disintegrins and C-Type Lectins to Anti-Platelet Drugs
Snake venoms are attractive natural sources for drug discovery and development, with a number of substances either in clinical use or in research and development.
Philip Lazarovici +2 more
doaj +3 more sources

